SUMMA Bio-Solutions
SUMMA Bio-Solutions is a biotechnology company focused on developing cellular medical solutions for degenerative medical conditions affecting both humans and animals. The company leverages advanced research and technology to provide innovative therapies aimed at improving health outcomes through bioscience.
SUMMA Bio-Solutions
500 8th Avenue, Fort Worth, Texas 76104, United States
What We Do
Cell Banking
Processing of submitted peripheral blood for recovery of nPSCs for immediate use in addressing various degenerative medical conditions.
Therapeutics
Development of therapeutic applications using stem cell conditioned medium and naturally occurring pluripotent stem cells.
Diagnostics
Utilization of nPSCs for diagnostic purposes, including the in vitro production of 3D organoids.
Tissue Engineering
Creation of 3D organoid tissues for research and therapeutic applications.
A proprietary method to isolate naturally occurring pluripotent stem cells from human and animal peripheral blood, applicable in therapeutics, diagnostics, and tissue engineering.
A novel technology for producing a conditioned medium from adipose-derived mesenchymal stem cells, aimed at treating inflammatory conditions.
Application Area
Digital Health Technologies
Biologics
Key People
Dr. Vasilis Paspaliaris
President and Chairman
Dr. William Steve Brown
Chief Executive Officer
Mr. Peter Milonas
Chief Operating Officer
Dr. George Kolios
Chief Medical & Scientific Officer
Mr. Doug Centilli
Director
David Strawn
Director Legal and Compliance
News & Updates
A Simplified Approach: Isolation of Small Pluripotent Stem Cells Derived from Human Peripheral Blood
This article discusses the challenges and advancements in isolating very small embryonic-like stem cells for regenerative medicine.
Research on the effects of conditioned medium from human adipose-derived stem cells on inflammation and fibrosis in lung conditions.